US-listed stock · IBRX

ImmunityBio, Inc. (IBRX): trades by Congress and insiders

In the last 12 months, 1 member of Congress disclosed 2 trades (2 buys, 0 sales); company insiders filed 2 open-market sales.

Congress trades

212 months

Members trading

112 months

Insider buys / sales

0 / 212 months

Last close

$9.8013 Oct 2026

One-year change

+295.2%

4 disclosed buys and sales on record since 6 October 2026; Congress bought an estimated $16 thousand and sold $0 in the last 12 months. Insider counts are open-market trades only: awards, option exercises and tax withholding are left out.

Members of Congress who traded IBRX

Last three years, by number of disclosed trades.

• Lisa McClain House · R-MI2 trades

Latest disclosures